Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Net Margin (2019 - 2025)

Historic Net Margin for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to 41.92%.

  • Biodesix's Net Margin rose 166600.0% to 41.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 49.85%, marking a year-over-year increase of 165800.0%. This contributed to the annual value of 59.95% for FY2024, which is 437000.0% up from last year.
  • Latest data reveals that Biodesix reported Net Margin of 41.92% as of Q3 2025, which was up 166600.0% from 58.03% recorded in Q2 2025.
  • In the past 5 years, Biodesix's Net Margin registered a high of 21.6% during Q1 2021, and its lowest value of 238.21% during Q1 2022.
  • Over the past 5 years, Biodesix's median Net Margin value was 91.44% (recorded in 2024), while the average stood at 107.16%.
  • Its Net Margin has fluctuated over the past 5 years, first soared by 1722600bps in 2021, then tumbled by -2166100bps in 2022.
  • Biodesix's Net Margin (Quarter) stood at 182.38% in 2021, then rose by 6bps to 171.13% in 2022, then skyrocketed by 63bps to 62.71% in 2023, then skyrocketed by 34bps to 41.12% in 2024, then dropped by -2bps to 41.92% in 2025.
  • Its last three reported values are 41.92% in Q3 2025, 58.03% for Q2 2025, and 60.26% during Q1 2025.